Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

September 3, 2018 Issue

09635-cover-mrna.jpg

September 3, 2018 Cover

Volume 96, Issue 35

Messenger RNA technology promises to turn our bodies into medicine-making factories. But first Moderna—and a long list of old and new competitors—needs to overcome some major scientific challenges

Cover:Several biotech companies use lipid nanoparticles to shuttle mRNA into cells, where the ribosome translates it into therapeutic proteins.

Credit: Ella Maru Studio

Full Article
Volume 96 | Issue 35

All Issues

Quote of the Week

“We are discovering things that we hope will rewrite the textbooks.”

Melissa Moore, chief scientific officer , Moderna Therapeutics

Can mRNA disrupt the drug industry?

Messenger RNA technology promises to turn our bodies into medicine-making factories. But first Moderna—and a long list of old and new competitors—needs to overcome some major scientific challenges

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT